KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Assets Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 3.73%
Dec 28, 2025 10.61%
Sep 28, 2025 8.15%
Jun 29, 2025 6.79%
Mar 30, 2025 12.62%
Dec 29, 2024 7.49%
Sep 29, 2024 7.36%
Jun 30, 2024 -5.53%
Mar 31, 2024 -12.25%
Dec 31, 2023 -10.58%
Oct 1, 2023 -5.18%
Jul 2, 2023 7.86%
Apr 2, 2023 9.88%
Jan 1, 2023 2.94%
Oct 2, 2022 -2.29%
Jul 3, 2022 0.73%
Apr 3, 2022 3.36%
Jan 2, 2022 4.07%
Oct 3, 2021 5.00%
Jul 4, 2021 11.40%
Apr 4, 2021 11.31%
Jan 3, 2021 10.88%
Sep 27, 2020 9.76%
Jun 28, 2020 2.10%
Mar 29, 2020 3.33%
Dec 29, 2019 3.12%
Sep 29, 2019 -0.12%
Jun 30, 2019 -0.16%
Mar 31, 2019 -4.21%
Dec 30, 2018 -2.76%
Sep 30, 2018 0.03%
Jul 1, 2018 1.67%
Apr 1, 2018 8.08%
Dec 31, 2017 11.40%
Oct 1, 2017 10.89%
Jul 2, 2017 9.29%
Apr 2, 2017 6.38%
Jan 1, 2017 5.84%
Oct 2, 2016 5.33%
Jul 3, 2016 5.89%
Apr 3, 2016 5.94%
Jan 3, 2016 2.34%
Sep 27, 2015 0.88%
Jun 28, 2015 -2.34%
Mar 29, 2015 -3.56%
Dec 28, 2014 -1.75%
Sep 28, 2014 4.07%
Jun 29, 2014 8.75%
Mar 30, 2014 9.70%
Dec 29, 2013 9.34%
Sep 29, 2013 6.71%
Jun 30, 2013 7.41%
Mar 31, 2013 4.60%
Dec 30, 2012 6.78%
Sep 30, 2012 6.38%
Jul 1, 2012 3.24%
Apr 1, 2012 7.44%
Jan 1, 2012 10.43%
Oct 2, 2011 13.82%
Jul 3, 2011 21.47%
Apr 3, 2011 15.74%
Jan 2, 2011 8.69%
Oct 3, 2010 7.31%
Jul 4, 2010 5.56%